Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
NCT05907681 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-06-29
Summary
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Conditions
- Breast Cancer
- Metastatic Breast Cancer
- Radiation Therapy Complication
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Haeyoung Kim · Samsung Medical Center
Eligibility
- Min Age
- 19 Years
- Max Age
- 100 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-11
- Primary Completion
- 2028-12-31
- Completion
- 2033-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT05592938 ·Status: RECRUITING ·Phase: NA
-
SMC Radiation Oncology Breast Cancer Cohort Study
NCT05775757 ·Status: RECRUITING
-
Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)
NCT05505357 ·Status: RECRUITING ·Phase: NA
-
Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing
NCT03475979 ·Status: UNKNOWN
-
Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy
NCT01257152 ·Status: COMPLETED
-
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer
NCT03617341 ·Status: UNKNOWN
-
Prospective Radiomics Study for Breast Cancer
NCT06095414 ·Status: COMPLETED
-
Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
NCT06677944 ·Status: RECRUITING ·Phase: PHASE2
-
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
NCT05976412 ·Status: RECRUITING ·Phase: NA
-
Comparison of Ultrasound and Breast MRI for Breast Cancer Detection
NCT05797545 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation
NCT04368442 ·Status: UNKNOWN
-
LAG3 Expression in Triple Negative Breast Cancer
NCT06259162 ·Status: RECRUITING ·Phase: NA
-
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
NCT05464082 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT06212440 ·Status: COMPLETED ·Phase: NA
-
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748 ·Status: RECRUITING ·Phase: PHASE2
-
Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery
NCT02617082 ·Status: UNKNOWN
-
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer
NCT03863301 ·Status: WITHDRAWN ·Phase: PHASE2
-
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT05291507 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT06635980 ·Status: RECRUITING ·Phase: PHASE2
-
Decision Impact Study of PreciseDx Breast
NCT06309615 ·Status: NOT_YET_RECRUITING
-
Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial
NCT04116125 ·Status: UNKNOWN ·Phase: NA
-
Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
NCT05896865 ·Status: RECRUITING ·Phase: NA
-
Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.
NCT03273426 ·Status: COMPLETED ·Phase: NA
-
HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC
NCT06830382 ·Status: RECRUITING